Insights

Gathering insights about 0…

Similar companies to 0

0 Tech Stack

0 uses 8 technology products and services including Snowplow, Comscore, Amazon CloudFront, and more. Explore 0's tech stack below.

Snowplow
Analytics
Comscore
Analytics
Amazon CloudFront
Content Delivery Network
JSON-LD
Javascript Frameworks
Vue.js
Javascript Frameworks
jQuery
Javascript Libraries
Yodel
Logistics
Primis
Online Video Platforms

Media & News

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of 10X Capital Venture Acquisition Corp. III (VCXB WS)
NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants of 10X Capital Venture Acquisition Corp. III (the “Company”), each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share — ticker symbol VCXB WS — from the NYSE American. Trading in the Company's warrants will be suspended immediately. Trading in the Compa.
Jun 25, 2024 | www.businesswire.com
10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-K Filing
New York, NY, April 23, 2024 (GLOBE NEWSWIRE) -- 10X Capital Venture Acquisition Corp. III (NYSE American: VCXB) (“10X III”), announced today that New York Stock Exchange Regulation, Inc., by letter dated April 17, 2024 (the “Notice”), notified 10X III that it was not in compliance with the NYSE American LLC's (“NYSE American”) continued listing standards because 10X III did not timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Annual Report”), which was due on April 16, 2024. 10X III was unable to timely file the Annual Report because 10X III's independent registered public accounting firm required additional time to complete its review of 10X III's financial statements for the year ended December 31, 2023.
Apr 23, 2024 | www.globenewswire.com
10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Noncompliance
New York, NY, Jan. 31, 2024 (GLOBE NEWSWIRE) -- 10X Capital Venture Acquisition Corp. III (NYSE American: VCXB, VCXB.U, VCXB WS) (“10X III”), announced today that NYSE Regulation (“NYSER”), by letter dated January 29, 2024 (the “Notice”), notified 10X III that it is not currently in compliance with Section 1003(b)(i) of the NYSE American LLC Company Guide because 10X III has fewer than 300 public shareholders. The Notice provides that 10X III has until February 28, 2024 (the “Compliance Plan Due Date”) to submit a plan to NYSER outlining how it intends to cure the deficiency and regain compliance with the NYSE American LLC's (the “NYSE American”) continued listing standards by January 14, 2025. The plan will be reviewed by NYSER. NYSER will either accept the plan, at which time 10X III will be subject to quarterly monitoring for compliance with this plan, or NYSER will not accept the plan and 10X III will be subject to suspension and delisting procedures. 10X III intends to submit a plan by the Compliance Plan Due Date.
Jan 31, 2024 | www.globenewswire.com
10X Capital Venture Acquisition Corp. III Announces Expected Change in Management
NEW YORK, NY (United States), Jan. 08, 2024 (GLOBE NEWSWIRE) -- 10X Capital Venture Acquisition Corp. III (“10X III”) (NYSE American:VCXB), a publicly traded special purpose acquisition company, announced today that, subject to approval by the board of directors, it expects David Weisburd, the current Chief Operating Officer and Head of Origination, to succeed Hans Thomas as Chief Executive Officer of 10X III, and expects Osman Ahmed to succeed Oliver Wriedt as President. Mr. Thomas will remain as Chairman of the board of directors.
Jan 08, 2024 | www.globenewswire.com
10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-Q Filing
New York, NY, Nov. 28, 2023 (GLOBE NEWSWIRE) -- 10X Capital Venture Acquisition Corp. III (NYSE American: VCXB) (“10X III”), announced today that New York Stock Exchange Regulation, Inc., by letter dated November 21, 2023 (the “Notice”), notified 10X III that it was not in compliance with the NYSE American LLC's (“NYSE American”) continued listing standards because 10X III did not timely file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “Quarterly Report”), which was due on November 20, 2023.
Nov 28, 2023 | www.globenewswire.com
10X Capital Venture Acquisition Corp. III Announces Transfer of Listed Securities to the NYSE American
New York, NY, Oct. 04, 2023 (GLOBE NEWSWIRE) -- 10X Capital Venture Acquisition Corp. III (NYSE: VCXB.U, VCXB, VCXB WS) (“10X III”) today announced that it is transferring the listing of its Class A ordinary shares, par value $0.0001 per share (“Class A Ordinary Shares”), redeemable warrants, each exercisable to purchase one Class A Ordinary Share at a price of $11.50 per share (the “Warrants”), and units, each consisting of one Class A Ordinary Share and one-half of one Warrant (the “Units” and, together with the Class A Ordinary Shares and the Warrants, the “Listed Securities”), from the New York Stock Exchange (the “NYSE”) to the NYSE American LLC (the “NYSE American”). 10X III's decision to transfer to the NYSE American was motivated by several factors, including more favorable thresholds for continued listing on the NYSE American. Following the transfer, 10X III intends to continue to file the same types of periodic reports and other information it currently files with the Securities and Exchange Commission (the “SEC”). 10X III expects that the trading of its Listed Securities on the NYSE will end at market close on or about October 6, 2023 and that the trading of its Listed Securities on the NYSE American will commence at market open on or about October 9, 2023 under the current ticker symbols, VCXB, VCXB WS and VCXB.U for the Class A Ordinary Shares, Warrants and Units, respectively.
Oct 04, 2023 | www.globenewswire.com
Correction: Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to go Public Through Business Combination With 10X Capital Venture Acquisition Corp. III
NEW YORK CITY, NEW YORK and ROCKVILLE, MARYLAND, Aug. 09, 2023 (GLOBE NEWSWIRE) -- NEW YORK CITY, NEW YORK and ROCKVILLE, MARYLAND, Aug. 9, 2023 (GLOBE NEWSWIRE) – American Gene Technologies International Inc. (“AGT”) and 10X Capital Venture Acquisition Corp. III (“10X III”) (NYSE: VCXB), a special purpose acquisition company, today announced that they have entered into a merger agreement for a business combination that would result in the combined company being a publicly listed company (the public company following the business combination to be renamed “Addimmune”). The combined company is expected to trade under the ticker symbol “HIV”. Addimmune is a clinical-stage gene and cell therapy company developing a functional cure for HIV. Prior to the combination, the non-HIV assets will spin-off into an entity that will retain the American Gene Technologies name.
Aug 09, 2023 | www.globenewswire.com

0's Email Address Formats

0 uses at least 2 format(s):

0 Email Formats	Example	Percentage
First@fqsalons.com	John@fqsalons.com	100%
FLast@merriam-webster.com	JDoe@merriam-webster.com	76%
First.Last@merriam-webster.com	John.Doe@merriam-webster.com	11%
LastF@merriam-webster.com	DoeJ@merriam-webster.com	8%
First_L@merriam-webster.com	John_D@merriam-webster.com	5%

Frequently Asked Questions

What is 0's stock symbol?

0 is a publicly traded company; the company's stock symbol is VCXB.

What is 0's official website and social media links?

0's official website is merriam-webster.com and has social profiles on LinkedIn.

What is 0's NAICS code?

0's NAICS code is 236 - Construction of Buildings.

How many employees does 0 have currently?

As of July 2026, 0 has approximately 4 employees across 1 continents, including North America. Key team members include President: J. P.Salon Manager: A. B.Salon Manager: A. B.. Explore 0's employee directory with LeadIQ.

What industry does 0 belong to?

0 operates in the Building Construction industry.

What technology does 0 use?

0's tech stack includes SnowplowComscoreAmazon CloudFrontJSON-LDVue.jsjQueryYodelPrimis.

What is 0's email format?

0's email format typically follows the pattern of First@fqsalons.com. Find more 0 email formats with LeadIQ.

When was 0 founded?

0 was founded in 2012.

0

Q: What is 0's official website and social media links?

0's official website is merriam-webster.com. 0 has social profiles on LinkedIn.

Q: How many employees does 0 have currently?

0 has approximately 4 employees.

Q: What technology does 0 use?

0's tech stack includes Unpkg, jQuery, Ubuntu, Google Workspace, Facebook.

Q: What is 0's NAICS code?

0's NAICS code is 236 (Construction of Buildings).

Building ConstructionTexas, United States2-10 Employees

0 is categorized within the Building Construction industry and is located in Spring, Texas. The available data indicate a small organization, with a workforce estimated between two and ten employees. The information does not include a description of the company’s products or services. The only listed web address is merriam-webster.com, and no additional context is provided about operations or founding details.

Company Overview

Website: merriam-webster.com
Stock Symbol: VCXB
NAICS Code: 236 - Construction of Buildings
Founded: 2012
Employees: 2-10

Media & News

Funding & Financials

$1M$10M
0's revenue is estimated to be in the range of $1M$10M

Funding & Financials

$1M$10M
0's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to 0

Knotel

WeWork

Salon Lofts

Serendipity Labs

Office Evolution

My Salon Suite

Industrious

The Regus Group

Sola Salon Studio

0 Tech Stack

Media & News

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of 10X Capital Venture Acquisition Corp. III (VCXB WS)

10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-K Filing

10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Noncompliance

10X Capital Venture Acquisition Corp. III Announces Expected Change in Management

10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-Q Filing

10X Capital Venture Acquisition Corp. III Announces Transfer of Listed Securities to the NYSE American

Correction: Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to go Public Through Business Combination With 10X Capital Venture Acquisition Corp. III

0's Email Address Formats

Frequently Asked Questions

What is 0's stock symbol?

What is 0's official website and social media links?

What is 0's NAICS code?

How many employees does 0 have currently?

What industry does 0 belong to?

What technology does 0 use?

What is 0's email format?

When was 0 founded?

0

Company Overview

Media & News

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of 10X Capital Venture Acquisition Corp. III (VCXB WS)

10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-K Filing

10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Noncompliance

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?